News | Cath Lab | April 25, 2022

NewYork-Presbyterian Hudson Valley Hospital Launches Interventional Cardiology Program and Opens State-of-the-Art Cardiac Catheterization Lab

The new interventional cardiology program will provide advanced cardiac intervention services, expanding access to the hospital’s team of leading specialists and expert care.
 

Celebrating the opening of new Interventional Cardiology Suite at NewYork-Presbyterian Hudson Valley Hospital

Celebrating the opening of new Interventional Cardiology Suite at NewYork-Presbyterian Hudson Valley Hospital


April 25, 2022 – NewYork-Presbyterian Hudson Valley Hospital celebrated the launch of its interventional cardiology program and the opening of its new cardiac catheterization laboratory, designed to support cardiac health and bring world-class interventional cardiology care to the Hudson Valley and upper Westchester region.

“NewYork-Presbyterian Hudson Valley Hospital and NewYork-Presbyterian Medical Group Hudson Valley cardiologists have been caring for our community’s hearts for decades,” said Stacey Petrower, president of NewYork-Presbyterian Hudson Valley Hospital. “We pride ourselves on serving our community, and are pleased to now be providing emergent life-saving intervention, in addition to diagnostic and preventive medical procedures, close to home.”

Dr. Giora Weisz
Dr. Giora Weisz, medical director of interventional cardiology at NewYork-Presbyterian Hudson Valley Hospital and an associate professor of medicine at Columbia University Vagelos College of Physicians and Surgeons.

“We look forward to further improving the cardiac care for residents of our surrounding communities and providing comprehensive on-site care for patients already treated at our hospital,” said Dr. Giora Weisz, medical director of interventional cardiology at NewYork-Presbyterian Hudson Valley Hospital and an associate professor of medicine at Columbia University Vagelos College of Physicians and Surgeons. “When it comes to cardiac emergencies, time is muscle. Having a catheterization lab close to home means patients will have speedier access to expert care, and that leads to better outcomes, especially for those experiencing a life-threatening event such as a heart attack.”

The interventional cardiology program provides a variety of emergent procedures, including cardiac angioplasty to improve blood flow in narrow or blocked arteries for patients experiencing a heart attack or chest pain. Advanced cardiac services include diagnostic cardiac catheterization (a procedure in which a catheter is guided through a blood vessel in the heart to diagnose certain heart conditions) and minimally invasive procedures to open clogged arteries. These include percutaneous coronary intervention (PCI, also known as ‘balloon and stent procedure’) and endovascular peripheral arterial revascularization, as well as electrophysiology (EP) procedure services to restore heart rhythms. The interventional cardiology program is equipped with the most up to date, state-of-the-art equipment including novel catheters to image the blood vessels from the inside. Additionally, physicians provide pacemaker and defibrillator implantation for treatment of arrhythmias.

NewYork-Presbyterian Hudson Valley Hospital’s interventional cardiology program will be open for emergent cases 24 hours a day, seven days a week, and will have a structured schedule for diagnostic and non-emergent procedures. Patients who may require cardiac surgery will have easy access to surgeons at NewYork-Presbyterian/Columbia University Irving Medical Center, establishing seamless team-oriented continuity of care.

The 8,500-square-foot facility was designed in collaboration with Jeffrey Berman Architect, OLA Consulting Engineers and Severud Associates, and is part of a broader initiative to enhance cardiac services across NewYork-Presbyterian's health system.

For more information: https://www.nyp.org/hudsonvalley


Related Content

News | Cardiovascular Business

September 28, 2023 — PaceMate, a market leading cardiac data management platform, announced today industry partnership ...

Home September 28, 2023
Home
News | Cardiovascular Business

September 28, 2023 — MarinHealth today announced that Pankaj Malhotra, MD, a non-invasive cardiologist with additional ...

Home September 28, 2023
Home
News | Cardiovascular Business

September 27, 2023 — The healthcare landscape has undergone rapid changes in recent years, requiring clinicians and ...

Home September 27, 2023
Home
News | Cardiovascular Business

September 27, 2023 — HeartBeam, Inc., a Santa Clara, CA-based cardiac technology company, has appointed Richa Gujarati ...

Home September 27, 2023
Home
News | Cardiovascular Business

September 21, 2023 — Many of the nation’s most prominent cardiovascular organizations, representing tens of thousands of ...

Home September 21, 2023
Home
News | Cardiovascular Business

September 15, 2023 — The American College of Cardiology (ACC) has recognized five Hackensack Meridian Health hospitals ...

Home September 15, 2023
Home
Feature | Cardiovascular Business | By Emily Gilbert and Kamran Zamanian, PhD

The global interventional cardiology device market is driven by the number of procedures performed across the globe. The ...

Home September 12, 2023
Home
News | Cardiovascular Business

September 11, 2023 — The Heart Rhythm Society (HRS) is gearing up for its second annual HRX event, bringing ...

Home September 11, 2023
Home
News | Cardiovascular Business

September 11, 2023 — Elucid, Inc., a leading medical technology company providing physicians with AI-powered imaging ...

Home September 11, 2023
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

As we wind down the summer months, DAIC takes a look at the Top 10 most-read pieces of content from www.dicardiology.com ...

Home August 31, 2023
Home
Subscribe Now